Below are the financial statements of Coloplast, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.
| All figures in billions of DKK | 2024 | 2023 |
|---|---|---|
| Income statement | — | — |
| Revenue | 27.03a | 24.5a |
| Production costs | -8.76a | -8.17a |
| Gross profit | 18.27a | 16.33a |
| Distribution costs | -8.83a | -7.52a |
| Administrative expenses | -1.24a | -1.12a |
| Research and development costs | -0.91a | -0.87a |
| Other operating income | 0.08a | 0.06a |
| Other operating expenses | -0.08a | -0.03a |
| Operating profit (EBIT) before special items | 7.29a | 6.85a |
| Special items | 0.03a | -0.07a |
| Operating profit (EBIT) | 7.32a | 6.77a |
| Financial income | 0.18a | 0.19a |
| Financial expenses | -1.1a | -0.94a |
| Profit before tax | 6.4a | 6.03a |
| Tax on profit for the year | -1.34a | -1.24a |
| Net profit for the year | 5.05a | 4.78a |
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Coloplast’s data sources below and access millions more through our Disclosure Search.
Sign up for Tracenable and access millions of corporate disclosures, including annual reports and sustainability filings from global companies, completely free of charge.